# TARGET Post-Approval Study

> **NCT02800863** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 426 (actual)

## Conditions studied

- Complex Regional Pain Syndrome (CRPS)

## Interventions

- **DEVICE:** Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System)
- **DEVICE:** Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System)

## Key facts

- **NCT ID:** NCT02800863
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-23
- **Primary completion:** 2021-09-23
- **Final completion:** 2021-09-23
- **Target enrollment:** 426 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02800863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02800863, "TARGET Post-Approval Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02800863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*